Search PubMed⌕ Search

Biomedical subjects

A B Stone

Publications and source records attributed to A B Stone.

31 records · Page 2Linked to original sources

Regulation of cell division in a temperature-sensitive division mutant of Escherichia coli.

Escherichia coli fil ts forms multinucleate filaments when suspensions of about 10(7) organisms per ml are shifted from 37 to 43 C in rich medium. Occasional septation continues, chiefly at the poles, and immediately becomes more frequent when the filaments are returned to 37 C. The addition of chloramphenicol (200 mug/ml) at either temperature initially stimulates the formation of polar septa. When very dilute suspensions of the strain (<10(6) organisms per ml) are shifted to the restrictive temperature, the inhibition of septation is more complete and only seldom reversible. Conversely, cell division is little affected when suspensions of >10(8) organisms per ml, or microcolonies of several hundred organisms on agar, are incubated at 43 C; evidence is presented that this is a consequence of a slight reduction in the mutant's growth rate. In certain media, septation is blocked irreversibly by even brief exposure to 43 C, after which cell elongation without division proceeds at 37 C for some hours. Several findings, when considered together, suggest that the cytoplasmic membrane is normal at the restrictive temperature, and that the block in septation is caused by a defect in the cell wall: it is largely overcome by NaCl, but not by sucrose; in some circumstances the filaments become swollen and develop localized bulges in the wall, yet the membrane remains intact and retains its selective permeability; lastly, the strain is insensitive to deoxycholate at both temperatures. The mutation has been mapped between arg B and thr, at a locus which appears to be distinct from others known primarily to influence cell division.

Cell Division↗

[Vaginal virucides against HIV].

Despite intensive efforts to promote condoms as a means of preventing the spread of HIV, the rate at which the epidemic is expanding, highlights the need for additional prevention technologies, and in particular methods controlled by women. Virucides are anti-infective substances, formulated as gels, foams, creams, and suppositories and impregnated sponges, for vaginal application. Women will be able to insert them prior to sexual intercourse to protect themselves and their partners from infection with HIV. Unlike condoms, the woman will control them, and their use can be with or without her partner's consent or even knowledge. They will not create a physical barrier to reduce sexual pleasure, and it will be possible to apply them considerably in advance of sex so that there is no interruption to the natural course of events. Virucides will not necessarily be contraceptive; ideally, they will be available in a choice of contraceptive and non-contraceptive versions. Virucides are not intended to replace other prevention measures such as those based on male and female condoms-or vaccines when they become available-but will give people a wider choice of potentially life-saving methods of protection. About 60 candidate virucides are in the development pipeline, representing many different chemical categories and different mechanisms of action against infection. About half a dozen are scheduled to enter large-scale clinical trials in the near future. Virucides offer the prospect of a low-cost, woman-controlled option for self-administered, broad-spectrum protection against multiple HIV strains, other sexually transmitted pathogens and unwanted pregnancy.

Administration, Intravaginal↗